NHS prescription charges in England to be frozen for first time in 12 years
May 16, 2022Sales and Marketing
The Department of Health has said that single prescription charges, which normally rise “in line with inflation”, will remain at …
Imfimzi for routine use on NHS England for patients with stage III unresectable lung cancer
May 16, 2022Sales and Marketing
AstraZeneca has announced the NICE recommendation of Imfinzi (durvalumab) for routine use within NHS England as a monotherapy for the …
Researchers pinpoint reason for Sudden Infant Deaths
May 16, 2022Sales and Marketing
Scientists from The Children’s Hospital Westmead in Sydney have discovered that babies who died of sudden infant death syndrome (SIDS) …
60,000 NHS staff believed to suffer pandemic-related PTSD
May 13, 2022Medical Communications
As many as 60,000 NHS staff are believed to be suffering from post-traumatic stress brought on by the COVID-19 pandemic, …
New national guidance addressing sepsis
May 13, 2022Medical Communications
New guidelines proposing significant changes to the way people with suspected sepsis are treated with antibiotics have been published. The …
Plant-based COVID-19 vaccine demonstrates 70% efficacy
May 12, 2022Business Services
The vaccine was developed by researchers at Canadian biotechnology company Medicago, and it contains coronavirus-like particles (CoVLP) produced in plants, …
Hypertensive pregnancy disorders linked to future cardiac events
May 12, 2022Business Services
A study funded by the US National Institutes of Health (NIH) has explained factors linked to increased risk for heart …
Phase III trial reveals positive results for Crohn’s disease treatment
May 12, 2022Business Services
AbbVie has announced positive topline results from U-ENDURE, its Phase III maintenance study, evaluating upadacitinib in adult patients with Crohn’s …
FDA approve Lilly-Incyte’s treatment for hospitalised COVID patients
May 12, 2022Business Services
The FDA has granted approval for Eli Lilly and Incyte’s Olumiant (baricitinib) to treat COVID-19 in adult patients admitted to …
SMC accepts chemotherapy-free VENCLYXTO for leukaemia treatment
May 11, 2022Research and Development
The SMC has accepted venetoclax in combination with obinutuzumab, for use within NHS Scotland, as a first-line treatment for patients …
Europe’s first psychedelic drug trial clinic to open in London
May 11, 2022Research and Development
British startup Clerkenwell Health aims to make the UK a global leader in psychedelic research and innovation, with Europe’s first …
Partnership researching genetics and treatments of long COVID
May 11, 2022Research and Development
PrecisionLife Limited have announced a partnership with Sano Genetics, a genetic research platform enabling patients to participate in ethical research …
WHO delivers 20 ambulances to Ukraine
May 10, 2022Manufacturing and Production
In efforts to support emergency health needs in Ukraine, WHO have given 20 all-terrain ambulances able to function in even …
MGC Pharma receives patent protection for epilepsy drug
May 10, 2022Manufacturing and Production
MGC Pharmaceuticals said a patent had been granted, protecting its unique system used to deliver a cannabis-derived drug being developed …
Fourth-dose COVID-19 jab demonstrates good boost
May 10, 2022Manufacturing and Production
A UK trial has revealed that fourth-dose COVID-19 booster vaccines increase protection against the disease, particularly those aged over 70. …
NIH discovery could advance precise therapies for blinding diseases
May 10, 2022Manufacturing and Production
Research at the National Institutes of Health (NIH) have identified distinct differences among the cells comprising a tissue in the …
Evofem’s Phase III trial reveals fewer UTIs in women using Phexxi
May 9, 2022Sales and Marketing
Evofem has announced new data from the Phase III AMPOWER clinical trial of Phexxi (lactic acid, citric acid, and potassium …
NIH launches clinical trial of vaccine for Epstein-Barr virus
May 9, 2022Research and Development
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched an …
FDA places partial clinical hold on BioCryst’s lead candidate, BCX9930
May 9, 2022Sales and Marketing
The FDA has imposed a partial clinical hold on BioCryst’s Factor D inhibitor, BCX9930. The clinical hold arrives around a …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
